PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26023F01832023-2024 influenza vaccine - PUGET SOUND — Sanofi Pasteur Inc

Sanofi Pasteur Inc holds $3.7B across 396 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 36E79723D0012. PoP ended Feb 29, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

260-Network Contract Office 20 (36C260)

Awarding office

Sanofi Pasteur Inc

Recipient

Feb 29, 2024

PoP end

$473K

Obligated

$473K

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Sanofi Pasteur Inc — $90

Contract facts

Federal

Contract number36C26023F0183

Also listed as36C260-23-F-0183

Also listed as36E79723D0012-36C26023F0183

Agency260-Network Contract Office 20 (36C260)

Awarding office260-Network Contract Office 20 (36C260)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentSanofi Pasteur Inc

CAGE7V915

UEINCXBGGQ8YTU9

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36E79723D0012

Place of performanceSEATTLE WA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMar 1, 2023

PoP end (current)Feb 29, 2024

Obligated$473K

Current value$473K

Potential value$473K

2023-2024 INFLUENZA VACCINE - PUGET SOUND VACHS FLUZONER QUADRIVALENT HIGH DOSE PREFILLED SYRINGE NDC: 49281-0123-65 is a federal award for 260-Network Contract Office 20 (36C260) held by Sanofi Pasteur Inc. Estimated value $473K ($473K obligated). Current period of performance ends Feb 29, 2024. Place of performance: SEATTLE WA.

2023-2024 INFLUENZA VACCINE - PUGET SOUND VACHS FLUZONER QUADRIVALENT HIGH DOSE PREFILLED SYRINGE NDC: 49281-0123-65

Recompete timing

Public

● Past PoP end (905 days ago)

Current PoP ended Feb 29, 2024 (905 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Sanofi Pasteur Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.7B) · all agencies · Top 4 shown (98%); remaining ~2% is other agencies.

Department of Health and Human Services (HHS)$3.6B · 97%Department of Defense (DOD)$29.1M · 1%Department of Veterans Affairs (VA)$6.9M · 0%Department of State (DOS)$2.4M · 0%

Open full company profile →

Related awards

Same parent · incumbent

SPE2DP26F2910

8511928943!INFLUENZA VIRUS VAC

$3.0M

Sep 25, 2026

SPE2DP26F2847

8511923395!INFLUENZA VIRUS VAC

$2.9M

Sep 25, 2026

SPE2DP26F2909

8511928883!INFLUENZA VIRUS VAC

$824K

Sep 25, 2026

15F06724F0000477

TRAVEL VACCINES.

$504K

Dec 31, 2026

15F06726F0000243

SANOFI TRAVEL VACCINES

$200K

Dec 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26023F0183?

36C26023F0183 (2023-2024 influenza vaccine - PUGET SOUND) is a 260-Network Contract Office 20 (36C260) award with a potential value of $473K, currently held by Sanofi Pasteur Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-23-F-0183?

36C260-23-F-0183 is the dashed form of PIID 36C26023F0183 (2023-2024 influenza vaccine - PUGET SOUND), held by Sanofi Pasteur Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26023F0183?

260-Network Contract Office 20 (36C260) awarded 36C26023F0183 to Sanofi Pasteur Inc (potential $473K).

Who is the incumbent on 36C26023F0183?

Sanofi Pasteur Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint. The current period of performance ends Feb 29, 2024.

When does Sanofi Pasteur Inc’s 36C26023F0183 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 29, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Feb 16, 2023